HCLSIG/PharmaOntology/Meetings/2009-04-16 Conference Call
Conference Details
- Date of Call: Thursday April 16, 2009
- Time of Call: 12:00pm Eastern Daylight Time (EDT), 17:00 British Summer Time (BST)
- Dial-In #: +1.617.761.6200 (Cambridge, MA)
- Dial-In #: +33.4.89.06.34.99 (Nice, France)
- Dial-In #: +44.117.370.6152 (Bristol, UK)
- Participant Access Code: 42572 ("HCLS2").
- IRC Channel: irc.w3.org port 6665 channel #HCLS2 (see W3C IRC page for details, or see Web IRC)
- Duration: ~1h
- Convener: Susie
Agenda
- Review Actions
- Finalize questions - Christi
- Initial proposed classes and properties - John
- Poster for International Conference on BioMedical Ontology - Susie
- F2F plans - Susie
- AOB
Minutes
Attendees: Matthias, Colin, Holger, Sandor, Lynn, Bosse, Christi, Elgar, Susie
Apologies: Larisa
Topic: Action Items
Susie: http://esw.w3.org/topic/HCLSIG/PharmaOntology/Actions
Susie: Sandor, your action item was to look at three new roles - what progress?
sszalma: clinical team lead & medical team lead we have been discussing.
Susie: we had hoped to have finalized the roles by last time - we have to get it done by the f2f
susie: trish was going to review possible ontologies; had done some previously
susie: susie & christi to distribute icbo abstract; done
susie: i will find out from helen about sk2
susie: john was going to propose some classes and properties; done
Topic: Questions finalized...
susie: http://esw.w3.org/topic/HCLSIG/PharmaOntology/Roles
christi: mol&cell biol - how do we pull in the chemistry?
colin: I'll paste in the chemistry things from above
lynn: i'll edit the wiki page
colin: is there polypharmacology/off-target effects
christi: moving on to in vitro biologist...
lynn: for cell lines you should look at ATCC but it's not an ontology
christi: on to in vivo biology...
lynn: do we have obi?
christi: we need interspecies comparisons
lynn/colin: model organism databases
lynn: also entrez genes
colin: what about online mendelian inheritance in animals? sszalma: paolo romano (in italy) has done a cell line dictionary
sszalma http://nar.oxfordjournals.org/cgi/content/full/37/suppl_1/D925
matthias_samwald: an indian group has done a similar thing
sszalma that is the right reference
matthias_samwald: it's an owl ontology
colin: what is "vehicle"
christi: it's how the active ingredient is conveyed
christi: moving on to "clinical trial formulator"
lynn: there's a human phenotype ontology, and DO
bosse: who is the clinical trial formulator? someone within the pharma company? responsible for the study design? has md?
christi: yes
bosse: this is v similar in my mind to a lead physician: looks at scientific content of study
susie: can we rename the role with a slash to make it clear that it's more than one role?
bosse: "clinical trial formulator/lead physician view"
christi: do the questions seem comprehensive?
susie: yes
christi: moving on to "Clinical Decision Support System Implementer View" - making sense of the data
lynn: what's epoc?
susie: clinical trial ontology from stanford
lynn: copied long line of ontologies from question before
holger_stenzhorn: advanced clinical genomic trials (http://www.ifomis.org/acgt)
christi: questions look pretty comprehensive
christi: okay, statisticians
colin: obi probably best for statistics
lynn: pato for phenotypes
colin: sequence ontology for genotypes
susie: i could ask someone i know for more questions here
christi: marketing...
susie: we should merge these into the strategic view above?
susie: we also need sales
christi: do we have any ontologies?
colin: no
susie: what media should we use for advertising?
susie: is our advertising in compliance with regulatory authorities?
colin: and local laws
colin: rename to "Sales and Marketing view"
christi: Primary Care Clinician View colin: infectious disease ontology (ido)
lynn: core ido most relevant
christi: non-drug treatments? homoeopathic?
colin: lifestyle changes like stopping smoking/exercise
susie: also interferences with, for example, grapefruit
christi: add those ontologies to specialty medical provider
christi: moving on to specialty medical provider...
christi: moving on to health plan provider...
susie: would be good to be build it out a bit - helen from agfa and vipul kashyap (will be at f2f) may be able to help
lynn: what are the data sources on what is allowable?
colin: looking at http://www.nice.org.uk/
susie: at the f2f, let's ensure these people add stuff to the wiki.
susie: vipul mentioned the Health plan Model
christi: bye everyone. thanks for all of your input!
Topic: F2F
lynn: i'll be out of the country for the f2f
susie: f2f is 30/4 and 1/5
http://esw.w3.org/topic/HCLSIG/Meetings/2009-04-30_F2F
susie: if you're dialling in could you add your name to that page and say you're dialling in
susie: moving on to the f2f... a breakout session of 3 h: (1) poster (2) key entities (3) brainstorming around use cases
colin: when are breakout sessions?
susie: 1330 to 1630 EST
lynn: will there be a report?
susie: there will be task breakout reports - should be pretty self-describing
Topic: Proposed Classes
http://esw.w3.org/topic/HCLSIG/PharmaOntology/Ontology
susie: john madden has proposed some classes and properties
susie: identified on the basis of word count frequency - we will be discussing those at the f2f
susie: also think about what use cases we're interested in building out
holger_stenzhorn: how are we prioritizing this?
susie: focus on the roles
Topic: ICBO Poster
susie: we managed to submit a proposal for a poster for ICBO
susie: thank you everyone who contributed - holger and elgar have contributed already and it would be useful to discuss this at the f2f
susie: someone at the group will be there
colin: i will
susie: are you willing to stand in front of the poster?
colin: yes
holger_stenzhorn: who is putting this on paper? i am willing to help?
susie: thank you for all your contributions - we're filling a gap lots of people are interested in having filled